vs
Side-by-side financial comparison of Climb Global Solutions, Inc. (CLMB) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $182.4M, roughly 1.5× Climb Global Solutions, Inc.). Climb Global Solutions, Inc. runs the higher net margin — 1.8% vs 0.7%, a 1.1% gap on every dollar of revenue. On growth, Climb Global Solutions, Inc. posted the faster year-over-year revenue change (32.1% vs -16.5%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
CLMB vs HCM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $182.4M | $270.8M |
| Net Profit | $3.3M | $2.0M |
| Gross Margin | 14.5% | 37.7% |
| Operating Margin | 2.1% | -13.2% |
| Net Margin | 1.8% | 0.7% |
| Revenue YoY | 32.1% | -16.5% |
| Net Profit YoY | -9.5% | -83.6% |
| EPS (diluted) | $0.18 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $182.4M | — | ||
| Q4 25 | $193.8M | $270.8M | ||
| Q3 25 | $161.3M | — | ||
| Q2 25 | $159.3M | $277.7M | ||
| Q1 25 | $138.0M | $324.5M | ||
| Q4 24 | $161.8M | — | ||
| Q3 24 | $119.3M | — | ||
| Q2 24 | $92.1M | $305.7M |
| Q1 26 | $3.3M | — | ||
| Q4 25 | $7.0M | $2.0M | ||
| Q3 25 | $4.7M | — | ||
| Q2 25 | $6.0M | $455.0M | ||
| Q1 25 | $3.7M | $11.9M | ||
| Q4 24 | $7.0M | — | ||
| Q3 24 | $5.5M | — | ||
| Q2 24 | $3.4M | $25.8M |
| Q1 26 | 14.5% | — | ||
| Q4 25 | 15.4% | 37.7% | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 16.5% | 0.1% | ||
| Q1 25 | 16.9% | 48.0% | ||
| Q4 24 | 19.3% | — | ||
| Q3 24 | 20.3% | — | ||
| Q2 24 | 20.2% | 41.1% |
| Q1 26 | 2.1% | — | ||
| Q4 25 | 4.9% | -13.2% | ||
| Q3 25 | 4.3% | — | ||
| Q2 25 | 5.0% | -1.3% | ||
| Q1 25 | 3.5% | -5.0% | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 7.1% | — | ||
| Q2 24 | 4.6% | -9.0% |
| Q1 26 | 1.8% | — | ||
| Q4 25 | 3.6% | 0.7% | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 3.7% | 163.8% | ||
| Q1 25 | 2.7% | 3.7% | ||
| Q4 24 | 4.3% | — | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 3.7% | 8.4% |
| Q1 26 | $0.18 | — | ||
| Q4 25 | $1.51 | $0.00 | ||
| Q3 25 | $1.02 | — | ||
| Q2 25 | $1.30 | $0.52 | ||
| Q1 25 | $0.81 | $0.01 | ||
| Q4 24 | $1.52 | — | ||
| Q3 24 | $1.19 | — | ||
| Q2 24 | $0.75 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.8M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $118.4M | $1.2B |
| Total Assets | $458.8M | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.8M | — | ||
| Q4 25 | $36.6M | $1.4B | ||
| Q3 25 | $49.8M | — | ||
| Q2 25 | $28.6M | $1.4B | ||
| Q1 25 | $32.5M | $836.1M | ||
| Q4 24 | $29.8M | — | ||
| Q3 24 | $22.1M | — | ||
| Q2 24 | $48.4M | $802.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M |
| Q1 26 | $118.4M | — | ||
| Q4 25 | $116.6M | $1.2B | ||
| Q3 25 | $109.3M | — | ||
| Q2 25 | $105.2M | $1.2B | ||
| Q1 25 | $95.6M | $759.9M | ||
| Q4 24 | $90.6M | — | ||
| Q3 24 | $87.7M | — | ||
| Q2 24 | $79.8M | $740.1M |
| Q1 26 | $458.8M | — | ||
| Q4 25 | $460.2M | $1.8B | ||
| Q3 25 | $376.1M | — | ||
| Q2 25 | $420.7M | $1.8B | ||
| Q1 25 | $370.1M | $1.3B | ||
| Q4 24 | $469.2M | — | ||
| Q3 24 | $371.9M | — | ||
| Q2 24 | $302.8M | $1.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-11.9M | $8.2M | ||
| Q3 25 | $22.2M | — | ||
| Q2 25 | $-2.2M | $-72.9M | ||
| Q1 25 | $8.5M | $40.3M | ||
| Q4 24 | $16.0M | — | ||
| Q3 24 | $-3.6M | — | ||
| Q2 24 | $7.3M | $-39.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% |
| Q1 26 | — | — | ||
| Q4 25 | -1.70× | 4.21× | ||
| Q3 25 | 4.73× | — | ||
| Q2 25 | -0.37× | -0.16× | ||
| Q1 25 | 2.30× | 3.38× | ||
| Q4 24 | 2.29× | — | ||
| Q3 24 | -0.66× | — | ||
| Q2 24 | 2.13× | -1.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
